MediGuard.org reaches 2.5 million members
MediGuard members can actively manage their personal health and safety in regards to drug-drug and drug-disease interactions. It is a free and secure source of information for registered users who want to get informed, stay informed and share feedback about their medications. MediGuard.org has received vital support from patient advocacy groups and offers balanced and timely information to help patients manage their healthcare for themselves or loved ones.
Today, MediGuard.org is the largest single community of highly engaged, medically and demographically profiled patients who have consented to share personal health information. Initially launched as iGuard.org in the United States, the community name has now changed to MediGuard.org and local adaptations of the site are now available in the United Kingdom, Spain, France, Germany, and Australia.
“Three years ago Quintiles knew mobilizing patients would be essential in the New Health, but we had no idea patients would be so enthusiastic,” said John Ratliff, Quintiles President and Chief Operating Officer. “Having access to such an engaged, clinically profiled pool of patients is helping Quintiles design better, faster clinical trials; increase drug safety and comparative effectiveness research through faster observational studies, and even make research into genetic predictors of treatment success possible today.”
In addition to MediGuard.org, Quintiles recently launched ClinicalResearch.com to raise awareness, understanding and participation in clinical research. The site’s easy-to-use search tool enables site visitors to access the most complete list of trials around the globe and to locate relevant studies with only a postal code and condition of interest. Its more than 150,000 members are proactively notified of study opportunities in their area as they become available.
Both MediGuard.org and ClinicalResearch.com were recently honored by the Web Health Awards for empowering patients to make better informed health decisions.
Quintiles is the only fully integrated bio pharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
KEYWORDS: Australia United Kingdom United States Europe Asia Pacific North America Australia/Oceania France Germany North Carolina Spain
INDUSTRY KEYWORDS: Health Biotechnology Hospitals Pharmaceutical Social Media Communications